1-4 of 4
Wen-Son Hsieh
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B33: A novel isoform of the major 8p22 tumor suppressor Deleted in Liver Cancer 1 (DLC1) gene with growth suppression function is frequently silenced epigenetically in multiple tumors

John S.W. Low, Qian Tao, Hwee Koon Goh, Ka Man Ng, Wan Lu Woo, Richard F. Ambinder, Gopesh Srivastava, Meir Shamay, Anthony T.C. Chan, Nicholas C. Popescu, Wen-son Hsieh
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (7_Supplement): B33.
https://doi.org/10.1158/1078-0432.TCME10-B33
Published: 02 February 2016
View article titled, Abstract B33: A novel isoform of the major 8p22 tumor suppressor <em>Deleted in Liver Cancer 1 (DLC1)</em> gene with growth suppression function is frequently silenced epigenetically in multiple tumors
Journal Articles

A Phase II Study of the Efficacy and Safety of the Combination Therapy of the MEK Inhibitor Refametinib (BAY 86-9766) Plus Sorafenib for Asian Patients with Unresectable Hepatocellular Carcinoma

Ho Yeong Lim, Jeong Heo, Hye Jin Choi, Cheng-Yao Lin, Jung-Hwan Yoon, Chiun Hsu, Kun-Ming Rau, Ronnie T.P. Poon, Winnie Yeo, Joong-Won Park, Miah Hiang Tay, Wen-Son Hsieh, Christian Kappeler, Prabhu Rajagopalan, Heiko Krissel, Michael Jeffers, Chia-Jui Yen, Won Young Tak
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (23): 5976–5985.
https://doi.org/10.1158/1078-0432.CCR-13-3445
Published: 30 November 2014
View article titled, A Phase II Study of the Efficacy and Safety of the Combination Therapy of the MEK Inhibitor Refametinib (BAY 86-9766) Plus Sorafenib for Asian Patients with Unresectable Hepatocellular Carcinoma
Open the PDF for A Phase II Study of the Efficacy and Safety of the Combination Therapy of the MEK Inhibitor Refametinib (BAY 86-9766) Plus Sorafenib for Asian Patients with Unresectable Hepatocellular Carcinoma in another window
Includes: Supplementary data
Journal Articles

Pharmacodynamic Effects of Seliciclib, an Orally Administered Cell Cycle Modulator, in Undifferentiated Nasopharyngeal Cancer

Wen-Son Hsieh, Ross Soo, Bee-Keow Peh, Thomas Loh, Difeng Dong, Donny Soh, Lim-Soon Wong, Simon Green, Judy Chiao, Chun-Ying Cui, Yoke-Fong Lai, Soo-Chin Lee, Benjamin Mow, Richie Soong, Manuel Salto-Tellez, Boon-Cher Goh
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (4): 1435–1442.
https://doi.org/10.1158/1078-0432.CCR-08-1748
Published: 19 February 2009
View article titled, Pharmacodynamic Effects of Seliciclib, an Orally Administered Cell Cycle Modulator, in Undifferentiated Nasopharyngeal Cancer
Open the PDF for Pharmacodynamic Effects of Seliciclib, an Orally Administered Cell Cycle Modulator, in Undifferentiated Nasopharyngeal Cancer in another window
Journal Articles

The Stress-Responsive Gene GADD45G Is a Functional Tumor Suppressor, with Its Response to Environmental Stresses Frequently Disrupted Epigenetically in Multiple Tumors

Jianming Ying, Gopesh Srivastava, Wen-Son Hsieh, Zifen Gao, Paul Murray, Shuen-Kuei Liao, Richard Ambinder, Qian Tao
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (18): 6442–6449.
https://doi.org/10.1158/1078-0432.CCR-05-0267
Published: 15 September 2005
View article titled, The Stress-Responsive Gene <em>GADD45G</em> Is a Functional Tumor Suppressor, with Its Response to Environmental Stresses Frequently Disrupted Epigenetically in Multiple Tumors
Open the PDF for The Stress-Responsive Gene <em>GADD45G</em> Is a Functional Tumor Suppressor, with Its Response to Environmental Stresses Frequently Disrupted Epigenetically in Multiple Tumors in another window